Skip to main content
Top
Published in: European Journal of Nutrition 6/2009

01-09-2009 | Original Contribution

Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces

Authors: Maria Cristina Verdenelli, Francesca Ghelfi, Stefania Silvi, Carla Orpianesi, Cinzia Cecchini, Alberto Cresci

Published in: European Journal of Nutrition | Issue 6/2009

Login to get access

Abstract

Background

The possibility of using microbes to maintain health, and to prevent or treat disease is a topic as old as microbiology. The research of novel probiotic strains is important in order to satisfy the increasing request of the market and to obtain functional products in which the probiotic cultures are more active and with better probiotic characteristics than those already present on the market.

Aim of the study

In this study, the probiotic potential of Lactobacillus strains isolated from Italian elderly human faeces was investigated.

Methods

The Lactobacillus strains were identified and examined for resistance to gastric acidity and bile toxicity, adhesion to HT-29 cells, antimicrobial activities, antibiotic susceptibility and plasmid profile. Survival of the strains through human intestine was examined in a 3 months human feeding trial.

Results

Two strains, Lactobacillus rhamnosus IMC 501 and Lactobacillus paracasei IMC 502, tolerated well low pH and bile acids. In antimicrobial activity assays, both strains showed inhibitory properties towards selected potential harmful microorganisms, particularly against Candida albicans. The two selected strains expressed high in vitro adherence to HT-29 cells increasing this characteristic when they are used in combination and they were resistant to vamcomycin, colistin sulphate, gentamicin, oxolinic acid and kanamycin. Moreover, the two strains could be recovered from stools of volunteers after the feeding trials.

Conclusions

Lactobacillus rhamnosus IMC 501 and L. paracasei IMC 502 present favourable strain-specific properties for their utilisation as probiotics in functional foods and the high adhesion ability of the L. rhamnosus IMC 501 and L. paracasei IMC 502 used in combination, confirmed by both in vitro and in vivo study, indicate that the two bacterial strains could be used as health-promoting bacteria.
Literature
1.
go back to reference Adlerberth I, Ahrne S, Johansson ML, Molin G, Hanson LA, Wold AE (1996) A mannose specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol 62:2244–2251 Adlerberth I, Ahrne S, Johansson ML, Molin G, Hanson LA, Wold AE (1996) A mannose specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol 62:2244–2251
2.
go back to reference Ahn C, Thompson DC, Duncan C, Stiles ME (1992) Mobilization and location of the genetic determinant of chloramphenicol resistance from Lactobacillus plantarum ca TC2R. Plasmid 27:263–264CrossRef Ahn C, Thompson DC, Duncan C, Stiles ME (1992) Mobilization and location of the genetic determinant of chloramphenicol resistance from Lactobacillus plantarum ca TC2R. Plasmid 27:263–264CrossRef
3.
go back to reference Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A (1999) Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65:351–354 Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A (1999) Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65:351–354
4.
go back to reference Altschul SF, Boguski MS, Gish W, Wootton JC (1994) Issues in searching molecular sequence databases. Nat Genet 6(2):119–129CrossRef Altschul SF, Boguski MS, Gish W, Wootton JC (1994) Issues in searching molecular sequence databases. Nat Genet 6(2):119–129CrossRef
5.
go back to reference Anderson DG, McKay LL (1983) Simple and rapid method for isolating large plasmid DNA from lactic streptococci. Appl Environ Microbiol 46:549–552 Anderson DG, McKay LL (1983) Simple and rapid method for isolating large plasmid DNA from lactic streptococci. Appl Environ Microbiol 46:549–552
6.
go back to reference Annuk H, Shchepetova J, Kullisaar T, Songisepp E, Zilmer M, Mikelsaar M (2003) Characterization of intestinal lactobacilli as putative probiotic candidates. J Appl Microbiol 94:403–412CrossRef Annuk H, Shchepetova J, Kullisaar T, Songisepp E, Zilmer M, Mikelsaar M (2003) Characterization of intestinal lactobacilli as putative probiotic candidates. J Appl Microbiol 94:403–412CrossRef
7.
go back to reference Azuma Y, Sato M (2001) Lactobacillus casei increases the adhesion of Lactobacillus gasseri NY0509 to human intestinal Caco-2 cells. Biosci Biotechnol Biochem 65:2326–2329CrossRef Azuma Y, Sato M (2001) Lactobacillus casei increases the adhesion of Lactobacillus gasseri NY0509 to human intestinal Caco-2 cells. Biosci Biotechnol Biochem 65:2326–2329CrossRef
8.
go back to reference Bauer AW, Kirby WMM, Sherris JC, Turk M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496 Bauer AW, Kirby WMM, Sherris JC, Turk M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496
9.
go back to reference Bernet-Carnard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S (1997) The human L. acidophilus strain LA1 secretes a non bacteriocin anti-bacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63:2747–2753 Bernet-Carnard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S (1997) The human L. acidophilus strain LA1 secretes a non bacteriocin anti-bacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63:2747–2753
10.
go back to reference Bertazzoni Minelli E, Benini A, Marzotto M, Sbarbati A, Ruzzenente O, Ferrario R, Hendrinks H, Dellaglio F (2004) Assessment of novel probiotic Lactobacillus casei strains for the production of functional dairy foods. Int Dairy J 14:723–736CrossRef Bertazzoni Minelli E, Benini A, Marzotto M, Sbarbati A, Ruzzenente O, Ferrario R, Hendrinks H, Dellaglio F (2004) Assessment of novel probiotic Lactobacillus casei strains for the production of functional dairy foods. Int Dairy J 14:723–736CrossRef
11.
go back to reference Blum S, Reniero R (2000) Adhesion of selected Lactobacillus strains to enterocyte-like Caco-2 cells in vitro: a critical evaluation of reliability of in vitro adhesion assays. In: 4th work-shop, demonstration of nutritional functionality of probiotic foods. Rovaniemi, 25–28 February Blum S, Reniero R (2000) Adhesion of selected Lactobacillus strains to enterocyte-like Caco-2 cells in vitro: a critical evaluation of reliability of in vitro adhesion assays. In: 4th work-shop, demonstration of nutritional functionality of probiotic foods. Rovaniemi, 25–28 February
12.
go back to reference Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JR (1985) Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 47:84–89 Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JR (1985) Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 47:84–89
13.
go back to reference Coconnier MH, Bernet MF, Kernéis S, Chauvière G, Fourniat J, Servin AL (1993) Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett 110:299–305CrossRef Coconnier MH, Bernet MF, Kernéis S, Chauvière G, Fourniat J, Servin AL (1993) Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett 110:299–305CrossRef
14.
go back to reference Collado MC, Meriluoto J, Salminen S (2007) Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus? J Dairy Sci 90:2710–2716CrossRef Collado MC, Meriluoto J, Salminen S (2007) Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus? J Dairy Sci 90:2710–2716CrossRef
15.
go back to reference Cummings JH, Antoine J-M, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B (2004) Passclaim—gut health and immunity. Eur J Nutr [Suppl 2] 43:II/118-II/173 Cummings JH, Antoine J-M, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B (2004) Passclaim—gut health and immunity. Eur J Nutr [Suppl 2] 43:II/118-II/173
16.
go back to reference Fang W, Shi M, Huang L, Wang Y (1996) Antagonism of lactic acid bacteria towards Staphylococcus aureus and Escherichia coli on agar plates and in milk. Vet Res 27:3–12 Fang W, Shi M, Huang L, Wang Y (1996) Antagonism of lactic acid bacteria towards Staphylococcus aureus and Escherichia coli on agar plates and in milk. Vet Res 27:3–12
17.
go back to reference FAO/WHO (2001) Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO expert consultation, Cordoba FAO/WHO (2001) Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO expert consultation, Cordoba
18.
go back to reference Fernández MF, Boris S, Barbés C (2003) Probiotic properties of human Lactobacillus strains to be used in the gastrointestinal tract. J Appl Microbiol 94:449–455CrossRef Fernández MF, Boris S, Barbés C (2003) Probiotic properties of human Lactobacillus strains to be used in the gastrointestinal tract. J Appl Microbiol 94:449–455CrossRef
19.
go back to reference Fons M, Hege T, Ladire M, Raibaud P, Ducluzeau R, Maguin E (1997) Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance. Plasmid 37:199–203CrossRef Fons M, Hege T, Ladire M, Raibaud P, Ducluzeau R, Maguin E (1997) Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance. Plasmid 37:199–203CrossRef
20.
go back to reference Frere J (1994) Simple method for extracting plasmid DNA from lactic acid bacteria. Lett Appl Microbiol 18:227–229CrossRef Frere J (1994) Simple method for extracting plasmid DNA from lactic acid bacteria. Lett Appl Microbiol 18:227–229CrossRef
21.
go back to reference Grifoni A, Bazzicalupo M, Di Serio C, Fancelli S, Fani R (1995) Identification of Azospirillum strains by restriction fragment length polymorphism of the 16S rDNA and of the histidine operon. FEMS Microbiol Lett 127(1–2):85–91CrossRef Grifoni A, Bazzicalupo M, Di Serio C, Fancelli S, Fani R (1995) Identification of Azospirillum strains by restriction fragment length polymorphism of the 16S rDNA and of the histidine operon. FEMS Microbiol Lett 127(1–2):85–91CrossRef
22.
go back to reference Hudault S, Lievin V, Bernet-Camard MF, Servin A (1997) Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 63:13–518 Hudault S, Lievin V, Bernet-Camard MF, Servin A (1997) Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 63:13–518
23.
go back to reference Isolauri E, Salminen S, Ouwehand AC (2004) Probiotics. Best Pract Res Clin Gastroenterol 18(2):299–314CrossRef Isolauri E, Salminen S, Ouwehand AC (2004) Probiotics. Best Pract Res Clin Gastroenterol 18(2):299–314CrossRef
24.
go back to reference Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Møller PL, Michaelsen KF, Pærregaard A, Sandstrom B, Tvede M, Jakobsen M (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65:4949–4956 Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Møller PL, Michaelsen KF, Pærregaard A, Sandstrom B, Tvede M, Jakobsen M (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65:4949–4956
25.
go back to reference Kimura K, McCartney AL, McConnell MA, Tannock GW (1997) Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 63(9):3394–3398 Kimura K, McCartney AL, McConnell MA, Tannock GW (1997) Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 63(9):3394–3398
26.
go back to reference Klein G, Pack A, Bonaparte C, Reuter G (1998) Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 41:103–105CrossRef Klein G, Pack A, Bonaparte C, Reuter G (1998) Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 41:103–105CrossRef
27.
go back to reference Klein G, Hallmann C, Casas IA, Abad J, Louwers J, Reuter G (2000) Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. J Appl Microbiol 89:815–824CrossRef Klein G, Hallmann C, Casas IA, Abad J, Louwers J, Reuter G (2000) Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. J Appl Microbiol 89:815–824CrossRef
28.
go back to reference Ljung A, Wadström T (2006) Lactic acid bacteria as probiotic. Curr Issues Intest Microbiol 7:73–90 Ljung A, Wadström T (2006) Lactic acid bacteria as probiotic. Curr Issues Intest Microbiol 7:73–90
29.
go back to reference McCartney AL, Wenzhi W, Tannock GW (1996) Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl Environ Microbiol 62(12):4608–4613 McCartney AL, Wenzhi W, Tannock GW (1996) Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl Environ Microbiol 62(12):4608–4613
30.
go back to reference Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Doré J, Blaut M (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72(2):1027–1033CrossRef Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Doré J, Blaut M (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72(2):1027–1033CrossRef
31.
go back to reference NCCLS Standard (1997) Methods for antimicrobial susceptibility testing for anaerobic bacteria. Approved Standard-Fourth edition document, vol. 11, no. 17 NCCLS Standard (1997) Methods for antimicrobial susceptibility testing for anaerobic bacteria. Approved Standard-Fourth edition document, vol. 11, no. 17
32.
go back to reference Ouwehand AC, Isolauri E, Kirjavainen PV, Tölkkö S, Salminen SJ (2000) The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol 30:10–13CrossRef Ouwehand AC, Isolauri E, Kirjavainen PV, Tölkkö S, Salminen SJ (2000) The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol 30:10–13CrossRef
33.
go back to reference Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW (1990) Is there a role of lactobacilli in prevention of urogenital and intestinal infection? Clin Microbiol Rev 3:335–344 Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW (1990) Is there a role of lactobacilli in prevention of urogenital and intestinal infection? Clin Microbiol Rev 3:335–344
34.
go back to reference Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130:396S–402S Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130:396S–402S
35.
go back to reference Rönkä E, Malinen E, Saarela M, Rinta-Koski M, Aarnikunnas J, Palva A (2003) Probiotic and milk technological properties of Lactobacillus brevis. Int J Food Microbiol 82:63–74CrossRef Rönkä E, Malinen E, Saarela M, Rinta-Koski M, Aarnikunnas J, Palva A (2003) Probiotic and milk technological properties of Lactobacillus brevis. Int J Food Microbiol 82:63–74CrossRef
36.
go back to reference Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, Vos de WM, Fonde’n R, Saxelin M, Collins K, Mogensen G, Birkeland SE, Sandholm TM (1998) Demonstration of safety of probiotics—a review. Int J Food Microbiol 44:93–106CrossRef Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, Vos de WM, Fonde’n R, Saxelin M, Collins K, Mogensen G, Birkeland SE, Sandholm TM (1998) Demonstration of safety of probiotics—a review. Int J Food Microbiol 44:93–106CrossRef
37.
go back to reference Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78:491–497CrossRef Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78:491–497CrossRef
38.
go back to reference Silvi S, Verdenelli MC, Orpianesi C, Cresci A (2003) EU project Crownalife: functional foods, gut microflora and healthy ageing. Isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Engin 56:195–200CrossRef Silvi S, Verdenelli MC, Orpianesi C, Cresci A (2003) EU project Crownalife: functional foods, gut microflora and healthy ageing. Isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Engin 56:195–200CrossRef
39.
go back to reference Tannock GW, Luchansky JB, Miller L, Connell H, Thode-Andersen S, Mercer AA, Klaenhammer TR (1994) Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100–63. Plasmid 31:60–71CrossRef Tannock GW, Luchansky JB, Miller L, Connell H, Thode-Andersen S, Mercer AA, Klaenhammer TR (1994) Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100–63. Plasmid 31:60–71CrossRef
40.
go back to reference Tuomola (née Lehto) E, Salminen SJ (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 41:45–51CrossRef Tuomola (née Lehto) E, Salminen SJ (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 41:45–51CrossRef
41.
go back to reference Walter J, Tannock GW, Tilsala-Timisjarvi A et al (2000) Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 66(1):297–303CrossRef Walter J, Tannock GW, Tilsala-Timisjarvi A et al (2000) Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 66(1):297–303CrossRef
42.
go back to reference Williams JGK, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV (1990) DNA polymorphism amplified by arbitrary primers are useful as genetic markers. Nucleic Acid Res 18: 6531-65-35 Williams JGK, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV (1990) DNA polymorphism amplified by arbitrary primers are useful as genetic markers. Nucleic Acid Res 18: 6531-65-35
43.
go back to reference Woodford N, Johnson AP, Morrison D, Speller DCE (1995) Current perspective on glycopeptide resistance. Clin Microbiol Rev 8:585–615 Woodford N, Johnson AP, Morrison D, Speller DCE (1995) Current perspective on glycopeptide resistance. Clin Microbiol Rev 8:585–615
Metadata
Title
Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces
Authors
Maria Cristina Verdenelli
Francesca Ghelfi
Stefania Silvi
Carla Orpianesi
Cinzia Cecchini
Alberto Cresci
Publication date
01-09-2009
Publisher
D. Steinkopff-Verlag
Published in
European Journal of Nutrition / Issue 6/2009
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-009-0021-2

Other articles of this Issue 6/2009

European Journal of Nutrition 6/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine